← Back to Dashboard
Diagnostic Market Expansion

Whole Blood

Origin Data Source OpenAlex
Analysis Computed Jul 1, 2026
AI Synthesis & Market Narrative
The bloodstream infection testing market is experiencing significant growth, driven by rapid molecular diagnostics and direct analysis from whole blood samples. Regulatory frameworks for non-food animal blood banks and laboratory expansions in immunogenicity assessment further indicate a dynamic diagnostic market.
Correlated Linguistic Patterns
["Bloodstream Infection Testing Market" "rapid molecular diagnostics" "whole blood samples" "immunogenicity risk assessment"]
Driving Media Context
GlobeNewswire • Jun 26, 2026

Bloodstream Infection Testing Market Size to Reach USD 1,404.68 Million by 2035 | SNS Insider

The U.S. Bloodstream Infection Testing Market is projected to grow from USD 221.68 Million in 2025 to USD 355.49 Million by 2035, while Europe is expected to...
Www.gov.uk • Jun 25, 2026

Apply for a new non-food animal blood bank authorisation (NFABBA)

Apply to collect and store whole blood and blood products (such as plasma and red blood cells) for use in non-food animals to meet unforeseen or exceptional ...
FDA.gov • Jun 24, 2026

BK261357- SeCore CDx HLA Sequencing System

The SeCore CDx HLA Sequencing System is intended for the detection of human leukocyte antigen A-locus (HLA-A) alleles using genomic DNA isolated from whole b...
Financial Post • Jun 23, 2026

Dynacare Launches Canada’s First At-Home, Self-Collect Hormone Blood Tests

Designed to transform access to hormone health testing with convenient, at-home kits — Tests span women’s fertility-related hormones and men’s testosterone l...
PRNewswire • Jun 23, 2026

EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services

PROVIDENCE, R.I., June 23, 2026 /PRNewswire/ -- EpiVax, Inc., a recognized leader in immunogenicity risk assessment, announces the expansion of its laborator...
PRNewswire • Jun 23, 2026

EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services

PROVIDENCE, R.I., June 23, 2026 /PRNewswire/ -- EpiVax, Inc., a recognized leader in immunogenicity risk assessment, announces the expansion of its laborator...
GlobeNewswire • Jun 23, 2026

Dynacare Launches Canada's First At-Home, Self-Collect Hormone Blood Tests

Designed to transform access to hormone health testing with convenient, at-home kits -- Tests span women’s fertility-related hormones and men’s testosterone ...
War on the Rocks • Jun 18, 2026

Good Medicine Is Combat Power: Clinical Innovation and the Lessons of the Russo-Ukrainian War

War is a brutal driver of medical innovation. Russia’s full-scale invasion of Ukraine has forced clinicians and commanders alike to confront a hard truth: Su...
Nature.com • Jun 17, 2026

Analysis of 173,303 exomes and genomes in the Pakistan Genome Resource

The Pakistan Genome Resource compiles biobank data from 173,303 individuals with high familial relatedness, broadening the catalogue of human genetic variati...
Nature.com • Jun 17, 2026

Spatial distribution of the proteome in the human body and in cancers

A spatially resolved map of the human proteome across a variety of healthy tissues and cancers provides wide-ranging insights in developmental biology and on...